Drug Type Small molecule drug |
Synonyms NIM-811, SDZ 811, SDZ-811 + [2] |
Target |
Mechanism CYPA inhibitors(Cyclophilin A inhibitors), PPIB inhibitors(Cyclophilin B inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC62H111N11O12 |
InChIKeyRPJPZDVUUKWPGT-FOIHOXPVSA-N |
CAS Registry143205-42-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic hepatitis C genotype 1 | Phase 2 | US | 01 Sep 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | AU | 01 Sep 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | BE | 01 Sep 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | DE | 01 Sep 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | PR | 01 Sep 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | ES | 01 Sep 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | TW | 01 Sep 2009 | |
Hepatitis C | IND Application | CN | 12 Jun 2009 | |
Hepatitis C | IND Application | CN | 12 Jun 2009 |